EDAP TMS reported EUR25.18M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
AngioDynamics USD 81.95M 1.68M Sep/2025
Boston Scientific USD 4.13B 72M Sep/2026
EDAP TMS EUR 25.18M 6.37M Mar/2026
Henry Schein USD 3.27B 8M Sep/2026
Medtronic USD 7.92B 203M Jun/2026
Plus Therapeutics USD 8.15M 1.04M Mar/2026
Veracyte USD 133.73M 7.37M Sep/2026